(Q39103150)

9 September 2017

title

Basal cell carcinoma in a patient with acquired immunodeficiency syndrome: treatment with Mohs micrographic surgery fixed-tissue technique (English)

1 reference

9 September 2017

0 references

Hruza GJ

1

1 reference

9 September 2017

Snow SN

series ordinal

2

1 reference

9 September 2017

publication date

1 May 1989

1 reference

The Journal of dermatologic surgery and oncology

9 September 2017

published in

1 reference

9 September 2017

volume

15

1 reference

9 September 2017

issue

5

1 reference

9 September 2017

page(s)

545-551

1 reference

Basal cell carcinoma in a man with acquired immunodeficiency syndrome

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1989.TB03415.X

Metastatic basal cell carcinoma in acquired immunodeficiency syndrome-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1989.TB03415.X

Multiple squamous cell carcinomas and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1989.TB03415.X

Malignant lymphoma presenting as Kaposi's sarcoma in a homosexual man with the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1989.TB03415.X

Hodgkin's disease in homosexual men with generalized lymphadenopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1989.TB03415.X

Malignancies in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1989.TB03415.X

HTLV-III/LAV seroconversion following a deep intramuscular needlestick injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1989.TB03415.X

Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1989.TB03415.X

Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1989.TB03415.X

Epidermal Langerhans cells--a target for HTLV-III/LAV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1989.TB03415.X

Inactivation of lymphadenopathy associated virus by chemical disinfectants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1989.TB03415.X

Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1989.TB03415.X

Prospective study of clinical, laboratory, and ancillary staff with accidental exposures to blood or body fluids from patients infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-4725.1989.TB03415.X

10.1111/J.1524-4725.1989.TB03415.X

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference